Rick, Doblin-square

Rick Doblin

Founder and Executive Director; the Multidisciplinary Association for Psychedelic Studies (MAPS), USA
Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife, dog, and empty rooms from three children, one of whom is in college and two have graduated.

More from this expert

The effect size and enduring benefit of MDMA in PTSD has surpassed all expectation in Phase 3 trials

Podcasts iconPodcasts

Upcoming Healthed Webcast

Alcohol Addiction Assessment and Advice

Tuesday 3rd March, 7pm - 9pm AEDT

Speaker

Dr Richard Bradlow

Psychiatrist and Addiction Specialist; Medical Director, Victoria Clinic, Melbourne; Austin Hospital

Over one in five Australian adults are regularly consuming alcohol at a quantity that is hazardous to their health. Join Dr Richard Bradlow for this presentation where he will discuss how to identify these patients in primary care, how the issue can be raised and how clinicians can change patients' drinking behaviour.